384 results on '"Hunt, Gillian"'
Search Results
2. The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study.
3. Estimating the contribution of key populations towards HIV transmission in South Africa
4. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey
5. Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
6. Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000–2016: A Pooled Sequence Analysis
7. Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
8. Reply to Van de Wijer et al
9. Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV : A Multicountry Analysis
10. Forty years of research on open spina bifida
11. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
12. Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial
13. Resistance is common in paediatric patients failing ART in South Africa
14. Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study
15. High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa
16. HIV diagnostic challenges in breast-fed infants of mothers on antiretroviral therapy
17. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4–8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011–12 and 2012–13
18. Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
19. Sensitive Tenofovir Resistance Screening of HIV-1 From the Genital and Blood Compartments of Women With Breakthrough Infections in the CAPRISA 004 Tenofovir Gel Trial
20. Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa
21. A New Professionalism? Becoming a Chartered Teacher--Part I
22. Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial
23. Pretreatment HIV drug resistance among treatment naïve infants newly diagnosed with HIV in 2016 in Namibia: results of a nationally representative study
24. Persistent Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnudeoside Reverse-Transcriptase Inhibitor-Based Therapy
25. Epidemiology of SARS‐CoV‐2 infection and SARS‐CoV‐2 positive hospital admissions among children in South Africa
26. Re: Cross-Sectional Study of Determinants of Upper and Lower Urinary Tract Outcomes in Adults with Spinal Dysraphism—New Recommendations for Urodynamic Followup Guidelines?
27. Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial
28. Inventory of Northern Ireland's Ancient Woodland
29. Outcome In People With Open Spina Bifida At Age 35: Prospective Community Based Cohort Study
30. Neurological level at birth predicts survival to the mid-40s and urological deaths in open spina bifida: a complete prospective cohort study
31. Intermittent Catheterisation: Simple, Safe, And Effective But Underused
32. Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression
33. Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis
34. Pretreatment Human Immunodeficiency Virus (HIV) Drug Resistance Among Treatment-Naive Infants Newly Diagnosed With HIV in 2016 in Namibia: Results of a Nationally Representative Study.
35. Community-led cross-sectional study of social and employment circumstances, HIV and associated factors amongst female sex workers in South Africa: study protocol
36. HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey
37. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey
38. Evolution and Diversity of HIV-1 in Africa – a Review
39. Characterisation of Near-full Length Genome Sequences of Three South African Human Immunodeficiency Virus Type 1 Subtype C Isolates
40. Expectation of life and unexpected death in open spina bifida: 40 year complete, non-selective longitudinal cohort study
41. Patient evaluation of early discharge after hip arthroplasty: development of a measure and comparison of three centres with differing durations of stay
42. Characterisation of the Long Terminal Repeat Regions of South African Human Immunodeficiency Virus Type 1 Isolates
43. Epidemiology of SARS‐CoV‐2 infection and SARS‐CoV‐2 positive hospital admissions among children in South Africa.
44. Open spina bifida: birth findings predict long-term outcome
45. Predictors of employment in people with open spina bifida at the mean age of 35 years
46. HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
47. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping
48. Relation between sacral sparing and long term urological outcome in open spina bifida
49. An independent 40 year review of mortality in open spina bifida
50. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.